uridine has been researched along with Colorectal Cancer in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 11 (52.38) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosokawa, M; Iwakawa, S; Ueda, K | 1 |
| Brody, JR; Costantino, CL; Eshleman, JR; Gallmeier, E; Hucl, T; Kern, SE; van der Heijden, MS; Wikiewicz, AK; Winter, JM; Yeo, CJ; Zhu, H | 1 |
| Banerjee, D; Bertino, JR; Humeniuk, R; Mishra, PJ | 1 |
| Akram, M; Balasubramanian, I; Bhattacharya, B; Dong, D; Fichtner, I; Iacopetta, B; Loh, M; Salto-Tellez, M; Soo, RA; Soong, R; Tan, WL; Thakkar, B; Wong, L | 1 |
| Brackett, DJ; Do, SV; Gissel, KA; Jupe, ER; Lawrence, BP; Lerner, MR; Liu, Q; Schmittgen, TD; Zakrajsek, BA | 1 |
| Kemeny, NE; Leonard, GD | 1 |
| Cass, C; Emami, S; Kresolic, Z; Kumar, P; McEwan, AJ; Paproski, R; Wiebe, LI; Yang, J | 1 |
| Allegra, CJ; Grogan, L; Sotos, GA | 1 |
| Inaba, M; Mitsuhashi, J | 1 |
| Meterissian, S; Petrick, AT; Steele, G; Thomas, P | 1 |
| Harvey, BE; Thomas, P | 1 |
| Arpicco, S; Brusa, P; Cattel, L; Coppo, S; Crosasso, P; Dosio, F; Pacchioni, D | 1 |
| Arpicco, S; Brusa, P; Cattel, L; Crosasso, P; Dosio, F; Pacchioni, D; Schuber, F | 1 |
| Bertino, JR | 1 |
| Inaba, M; Mitsuhashi, J; Naoe, Y | 1 |
| Bentires-Alj, M; Bours, V; Fillet, G; Gielen, J; Hellin, AC; Lechanteur, C; Lopez, M; Merville, MP; Princen, F | 1 |
| Jeanteur, P | 1 |
| Franchi, F; Giannarelli, D; Konovalova, N; Seminara, P | 1 |
| Rapoza, A; Steele, G; Thomas, P; Wagner, HE; Wolf, BC | 1 |
| Colella, G; Giuliani, F; Sanfilippo, O; Silvestrini, R; Villa, R; Zaffaroni, N | 1 |
| Peters, GJ | 1 |
3 review(s) available for uridine and Colorectal Cancer
| Article | Year |
|---|---|
Preclinical and clinical aspects of biomodulation of 5-fluorouracil.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cisplatin; Colorectal Neoplasms; DNA, Neoplasm; Fluorouracil; Humans; Idoxuridine; Immunologic Factors; Interferons; Leucovorin; Methotrexate; Mice; Phosphonoacetic Acid; RNA, Neoplasm; Uracil; Uridine; Zidovudine | 1994 |
Chemotherapy of colorectal cancer: history and new themes.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Floxuridine; Fluorouracil; History, 20th Century; Humans; Prodrugs; Uridine | 1997 |
Preclinical and clinical biochemical modulation of 5-fluorouracil by leucovorin and uridine.
Topics: Animals; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Mice; Tumor Cells, Cultured; Uridine | 1988 |
18 other study(ies) available for uridine and Colorectal Cancer
| Article | Year |
|---|---|
Cellular Uptake of Decitabine by Equilibrative Nucleoside Transporters in HCT116 Cells.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carrier Proteins; Colorectal Neoplasms; Decitabine; DNA Methylation; Equilibrative Nucleoside Transporter 1; Gene Expression; HCT116 Cells; Humans; Melanoma-Specific Antigens; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thioinosine; Uridine | 2015 |
Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence.
Topics: Alleles; Antimetabolites, Antineoplastic; Base Sequence; Cell Line, Tumor; Colorectal Neoplasms; Fluorouracil; Genes, p53; HCT116 Cells; Humans; Molecular Sequence Data; Mutation; RNA, Messenger; RNA, Neoplasm; Thymidine; Thymidylate Synthase; Uridine; Yeasts | 2009 |
Epigenetic reversal of acquired resistance to 5-fluorouracil treatment.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Cell Line, Tumor; Colorectal Neoplasms; CpG Islands; Decitabine; DNA Methylation; Drug Resistance, Neoplasm; Epigenomics; Fluorouracil; Gene Expression Regulation, Neoplastic; Gene Order; Humans; Mice; Mice, Nude; Molecular Sequence Data; Nucleoside-Phosphate Kinase; Promoter Regions, Genetic; RNA Stability; Uridine; Xenograft Model Antitumor Assays | 2009 |
Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancer.
Topics: Animals; Apoptosis; Colorectal Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Humans; Mice; Pyrophosphatases; RNA, Small Interfering; Uridine; Xenograft Model Antitumor Assays | 2011 |
Diverse gene expression pattern during 5-fluorouridine-induced apoptosis.
Topics: Analysis of Variance; Apoptosis; Cell Survival; Cluster Analysis; Colorectal Neoplasms; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Microscopy, Electron; Necrosis; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Thymidine; Time Factors; Up-Regulation; Uridine | 2005 |
Continued survival of more than ten years, without resection of metastatic disease, in patients with metastatic colorectal cancer treated with biomodulated fluorouracil: report of two cases.
Topics: Acetates; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Colorectal Neoplasms; Female; Fluorouracil; Humans; Immunologic Factors; Leucovorin; Liver Neoplasms; Male; Methotrexate; Middle Aged; Phosphonoacetic Acid; Remission Induction; Uridine; Vitamin B Complex | 2006 |
Synthesis, transportability and hypoxiaselective binding of 1-beta-D-(5-Deoxy-5-fluororibofuranosyl)-2-nitroimidazole (beta-5-FAZR), a configurational isomer of the clinical hypoxia marker, FAZA.
Topics: Cell Hypoxia; Colorectal Neoplasms; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Gamma Rays; HCT116 Cells; Humans; Isomerism; Membrane Transport Proteins; Nitroimidazoles; Radiation-Sensitizing Agents; Uridine | 2007 |
Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells.
Topics: Cell Cycle; Cell Survival; Colorectal Neoplasms; DNA, Neoplasm; DNA, Ribosomal; Dose-Response Relationship, Drug; Flow Cytometry; Floxuridine; Fluorouracil; Humans; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uridine | 1994 |
Desialylation of metastatic human colorectal carcinoma cells facilitates binding to Kupffer cells.
Topics: Animals; Colorectal Neoplasms; Glycosides; Humans; Kupffer Cells; Liver Neoplasms; Mice; Mice, Nude; N-Acetylneuraminic Acid; Neoplasm Metastasis; Sialic Acids; Sialyltransferases; Tumor Cells, Cultured; Uridine | 1994 |
Inhibition of CMP-sialic acid transport in human liver and colorectal cancer cell lines by a sialic acid nucleoside conjugate (KI-8110).
Topics: beta-D-Galactoside alpha 2-6-Sialyltransferase; Binding, Competitive; Biological Transport; Colorectal Neoplasms; Cytidine Monophosphate; Cytidine Monophosphate N-Acetylneuraminic Acid; Glycosides; Humans; Liver; Microsomes; Microsomes, Liver; Sialyltransferases; Tumor Cells, Cultured; Uridine | 1993 |
In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Colorectal Neoplasms; Drug Stability; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunotoxins; Lethal Dose 50; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Protein Synthesis Inhibitors; Tumor Cells, Cultured; Uridine | 1997 |
Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Calorimetry, Differential Scanning; Colorectal Neoplasms; Drug Carriers; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Humans; Liposomes; Mice; Neoplasm Transplantation; Prodrugs; Tumor Cells, Cultured; Uridine | 1997 |
Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.
Topics: Antimetabolites, Antineoplastic; Cell Count; Colorectal Neoplasms; Drug Resistance, Neoplasm; Floxuridine; Fluorouracil; Humans; Intracellular Fluid; Phosphoribosyl Pyrophosphate; RNA, Neoplasm; Thymidylate Synthase; Tumor Cells, Cultured; Uridine | 1998 |
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma; Colorectal Neoplasms; Cytosine Deaminase; Disease Models, Animal; Feasibility Studies; Flucytosine; Genetic Therapy; Humans; Male; Neoplasm Transplantation; Nucleoside Deaminases; Peritoneal Neoplasms; Rats; Tumor Cells, Cultured; Uridine | 2000 |
[Nutrition, genetic polymorphism, and cancer].
Topics: Colorectal Neoplasms; DNA; DNA Repair; Folic Acid; Genotype; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasms; Nutritional Physiological Phenomena; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Tetrahydrofolates; Thymidine; Uridine | 2000 |
Fractional incorporation of radionucleotides, a marker of in vitro tumor cell chemosensitivity in colorectal cancer.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Daunorubicin; DNA, Neoplasm; Doxorubicin; Humans; In Vitro Techniques; Liver Neoplasms; Mitomycin; RNA, Neoplasm; Thymidine; Tritium; Tumor Cells, Cultured; Uridine | 1991 |
Inhibition of sialic acid incorporation prevents hepatic metastases.
Topics: Animals; Carcinoembryonic Antigen; Cell Line; Colorectal Neoplasms; Glycosides; Humans; Liver Neoplasms, Experimental; Male; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Transplantation; Sialic Acids; Tumor Cells, Cultured; Uridine | 1990 |
In vitro activity of 4'-iodo-4'-deoxydoxorubicin on human colo-rectal cancer as measured by a short-term antimetabolic assay.
Topics: Colorectal Neoplasms; Doxorubicin; Humans; Thymidine; Tumor Cells, Cultured; Uridine | 1990 |